Martin Turcotte

发表

Targeting A2 adenosine receptors in cancer

D. Allard, Martin Turcotte, J. Stagg, 2017, Immunology and cell biology.

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

Martin Turcotte, J. Stagg, B. Allard, 2012, Journal of biomedicine & biotechnology.

CD 73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

Deena M. A. Gendoo, Kathleen M Spring, Gregory M. Chen, 2015 .

CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.

C. Sotiriou, S. Loi, H. Joensuu, 2017, Cancer research.

Quasi-Unidimensional {[M(dmb)2]Y}n Organometallic Polymers (M = Cu(I), Ag(I); dmb = 1,8-Diisocyano-p-menthane; Y = BF4-, PF6-, NO3-, ClO4-, CH3CO2-).1a Structural, Calorimetric, and Luminescence Properties

D. Fortin, P. Harvey, M. Drouin, 1997 .

CD73 is associated with poor prognosis in high-grade serous ovarian cancer.

Deena M. A. Gendoo, Kathleen M Spring, Gregory M. Chen, 2015, Cancer research.

Characterization of the [Ag(dmb)(2)(+)](n) oligomers (dmb = 1,8-diisocyano-p-menthane) in solution.

P. Harvey, Martin Turcotte, 2002, Inorganic chemistry.

Anti‐CD73 therapy impairs tumor angiogenesis

Kathleen M Spring, Martin Turcotte, J. Stagg, 2014, International journal of cancer.

Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer

Martin Turcotte, J. Stagg, B. Allard, 2014, Expert opinion on therapeutic targets.

PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors.

L. Buisseret, D. Allard, P. Chrobak, 2017, Cancer research.

CD73-adenosine reduces immune responses and survival in ovarian cancer patients

P. Gaudreau, Martin Turcotte, J. Stagg, 2016, Oncoimmunology.

PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors.

L. Buisseret, D. Allard, P. Chrobak, 2017, Cancer research.